Form 4: Ultralife Corp Director Robert W. Shaw Acquires 4,000 Shares
SEC Form 4 Filing
Director Robert W. Shaw purchased 4,000 shares of Ultralife Corp common stock at $5.49 per share on May 14, 2025.
Summary
- On May 14, 2025, Robert W. Shaw, a director of Ultralife Corp, acquired 4,000 shares of common stock.
- The purchase price was $5.49 per share.
- Following the transaction, Shaw directly owns 69,250 shares of Ultralife Corp.
- The transaction was executed under transaction code 'P', indicating a purchase on the open market.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a relatively small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders of a company (officers, directors, or any individuals owning more than 10% of a company's shares) buy or sell the company's stock. These filings provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/14/2025 | Date of transaction: Robert W. Shaw purchased 4,000 shares of Ultralife Corp. |
Keywords
Ultralife Corp, Director, Robert W. Shaw, Stock Purchase, Form 4, ULBI, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.